Forward Industries Prepares Investment in Solana-Native DeFi Protocols
- Forward Industries Raises $1,65 Billion for Crypto Treasury
- Company intends to invest funds in Solana's DeFi protocols
- The goal is to consolidate institutional position against Ethereum
Forward Industries, a Nasdaq-listed company that recently repositioned itself as a treasury firm focused on the Solana network, announced plans to invest its resources in the growth of the blockchain's DeFi ecosystem. The initiative was confirmed by Kyle Samani, co-founder of Multicoin Capital and current president of Forward.
Last week, the company completed a $1,65 billion private placement, led by Multicoin Capital itself, along with Galaxy Digital and Jump Crypto. Together, the three asset managers contributed over $300 million, highlighting Forward Industries' ambition to transform it into a publicly traded institutional benchmark within the Solana ecosystem.
Samani reinforced the strategy in response to a post by trader and influencer Ansem no X, who stated that allocating corporate treasury funds to Solana's native protocols could strengthen the network's competitiveness against Ethereum. "This is the game plan," the executive wrote.
This is the game plan! https://t.co/Auu1HHx3I4
— Kyle Samani (@KyleSamani) September 14, 2025
Although Forward Industries has not yet announced a direct purchase of SOL, corporate treasuries collectively held over 4,7 million tokens as of September 14. This reinforces the movement of public treasuries to diversify and position themselves on alternative networks to Ethereum.
Solana has established itself in recent years as one of the main competitors to the network founded by Vitalik Buterin, offering lower transaction costs and greater processing power. Even so, the gap in terms of total value locked (TVL) across DeFi protocols remains significant. Ethereum currently hosts 1.601 protocols, which together account for over $96 billion in TVL, while Solana, with 363 protocols, holds approximately $13 billion, according to DefiLlama data .
Forward Industries' move signals a bet on an accelerated expansion of DeFi activity on Solana, supported by institutional liquidity and the growing interest of listed companies in adopting cryptocurrency treasury strategies as part of their growth models.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.
Crypto prices
More
